NCT01775020View on ClinicalTrials.gov

Dose-response Study of Arginine Supplementation in Severe Sepsis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2012

Conditions
SepsisSeptic Shock
Interventions
DIETARY_SUPPLEMENT

L-arginine

All Listed Sponsors
collaborator

Novartis Medical Nutrition

UNKNOWN

lead

Maastricht University Medical Center

OTHER

NCT01775020 - Dose-response Study of Arginine Supplementation in Severe Sepsis | Biotech Hunter | Biotech Hunter